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ABSTRACT 
Purpose of review 
Erythroblasts differentiate within specialized niches, termed erythroblastic islands, composed of 
erythroblasts surrounding a central macrophage. This review focuses on our current 
understanding of molecular mechanisms operating within islands including cell-cell adhesion, 
regulatory feedback and central macrophage function.  
Recent findings 
Erythroblasts express a variety of adhesion molecules and recently two interactions have been 
identified which appear to be critical for island integrity. Erythroblast macrophage protein 
(Emp), expressed on erythroblasts and macrophages, mediates cell-cell attachments via 
homophilic binding. Erythroblast intercellular adhesion molecule-4 (ICAM-4) links erythroblasts 
to macrophages through interaction with macrophage αv integrin. In ICAM-4 knockout mice 
erythroblastic islands are markedly reduced, while the Emp null phenotype is severely anemic 
and embryonic lethal. Perturbation in macrophage differentiation also severely affects 
erythropoiesis. Retinoblastoma tumor suppressor (Rb) protein stimulates macrophage 
differentiation by counteracting inhibition of Id2 on PU.1, a transcription factor that is a crucial 
regulator of macrophage differentiation. Rb deficient macrophages do not bind Rb null 
erythroblasts and the Rb null phenotype is anemic and embryonic lethal. Lastly, an important 
signal for phagocytosis of expelled nuclei has been identified. Extruded nuclei rapidly expose 
phosphatidylserine (PS) on their surface, providing a recognition signal similar to apoptotic 
cells.  
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ABSTRACT (CONTINUED) 
Summary 
Although our understanding of molecular mechanisms operating within islands is at an early 
stage, tantalizing evidence suggests that erythroblastic islands are specialized niches where 
intercellular interactions in concert with cytokines play critical roles in regulating erythropoiesis.  
Keywords 
erythroblastic islands, erythropoiesis, macrophage, erythroblast macrophage protein (Emp), 
intercellular adhesion molecule-4 (ICAM-4), Rb protein, GATA-1 
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INTRODUCTION 
     Mammalian erythroblasts proliferate, differentiate and enucleate within specialized 
microenvironmental niches, termed erythroblastic islands [1, 2, 3, 4]. Since we are approaching 
the 50th anniversary of the first description of erythroblastic islands by Dr. Marcel Bessis, it 
seems timely to focus a review on our current knowledge of the molecular characterization and 
functions of these compartments dedicated to terminal erythroid differentiation. Fetal liver, bone 
marrow and splenic erythropoiesis occur within erythroblastic islands, composed of developing 
erythroblasts surrounding a central macrophage (Figure 1) [2]. Areas of erythropoiesis in long 
term bone marrow cultures also contain central macrophages [1]. Reconstruction of 3-
dimensional models of bone marrow from serial sections show that islands are distributed over 
the entire marrow space and not localized to specific regions [4]. Although early electron 
microscopic analysis of thin sections suggest that central macrophages phagocytose extruded 
nuclei and supply iron to developing erythroblasts  [5], the role of central macrophages in iron 
metabolism is yet to be clearly delineated. Extensive cell-cell interactions, both erythroblast-
macrophage, as well as erythroblast-erythroblast occur within islands and, to date, several 
specific intercellular adhesive interactions have been defined. Although our current 
understanding of molecular mechanisms operating within islands is at an early stage, tantalizing 
evidence suggests that erythroblastic islands are highly specialized hematopoietic tissue 
subcompartments where intercellular interactions in concert with stimulatory and inhibitory 
cytokines play critical roles in regulating erythropoiesis and apoptosis.  
CELLULAR COMPOSITION AND STRUCTURE OF ISLANDS 
     During steady state erythropoiesis, erythroblastic islands are composed of erythroid cells at 
various stages of differentiation from CFU-E through young, multilobulated reticulocytes  [6, 7, 
8, 9, 10]. In the unstressed state there also appears to be variation in the number of cells per 
island. Tissue sections from rat femur reveal about 10 cells per island [10] while islands 
harvested from human marrow contain 5->30 erythroblasts per island [8].  
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      In hematopoietic tissues, central macrophages of erythroblastic islands are resident 
macrophages that have differentiated from monocyte precursors. Hence bone marrow contains 
monocytes/macrophages at various stages of differentiation and phenotype. Although phenotypic 
analysis of central macrophages is far from complete in any species on a genomic or proteomic 
level, certain specifics have been delineated. Currently, the two most useful markers for 
distinguishing mouse central macrophages from other stromal cells in hematopoietic tissues are 
F4/80 antigen and Forssman glycosphingolipid. F4/80 antigen is a cell surface glycoprotein with 
homology to the G-protein linked Transmembrane 7 hormone receptor family [11, 12, 13]. 
Forssman glycosphingolipid distinguishes central macrophages from monocytes and from bone 
marrow macrophages cultured with macrophage colony-stimulating factor (M-CSF) [14, 15, 16]. 
Immunophenotyping of central macrophages harvested from human bone marrow islands shows 
expression of FcRI, FcRII, FcRIII, CD4, CD31, CD11a, CD11c, CD18, CD31 and HLA-DR [8].   
     Erythroblastic islands are present in mammalian bone marrow and in splenic red pulp in 
certain species, such as mouse. In mouse fetal liver, definitive erythropoiesis also occurs in 
islands [17] but the question of whether primitive erythropoiesis does remains unanswered.  In 
contrast to definitive erythropoiesis, primitive erythroblasts are released into circulation as 
nucleated red cells and undergo enucleation while in circulation [18]. If the central macrophage 
has a functional role in enucleation of definitive fetal-, bone marrow- and splenic-derived 
erythroblasts, the observation that primitive erythroblasts do not enucleate during differentiation 
in the liver argues that they may not differentiate within islands. In support of this speculation is 
a report showing that mature avian red cells, that remain nucleated, differentiate in bone marrow 
that does not contain islands [19].   
CELL-CELL ADHESION 
     Although erythroblasts express a variety of cell adhesion molecules only a few involved in 
cell attachments within erythroblastic islands have been delineated to date. A 36kDa 
transmembrane protein Emp (erythroblast macrophage protein) has been discovered on both 
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erythroblast and macrophage surfaces, that appears capable of mediating erythroblast-
macrophage or erythroblast-erythroblast attachments via homophilic binding [3]. The 
cytoplasmic domain of Emp contains several potential binding sites for SH2 domains and a 
potential binding site for phosphotyrosine binding domain, suggesting signaling function. When 
erythroblasts are cultured in the absence of macrophages or in the presence of anti-Emp a six-
fold increase in apoptosis is observed, accompanied by a marked decrease in erythroid cell 
proliferation, maturation, and enucleation [20]. A recent report has shown that Emp null fetuses 
are severely anemic and die in utero [21*], strongly supporting a crucial role for Emp in 
erythropoiesis.  A second identified adhesive interaction within islands involves 
erythroblast/central macrophage binding mediated by erythroblast α4β1 integrin and its 
counterreceptor on central macrophages, VCAM-1 [22]. Antibodies to either α4β1 or VCAM-1 
disrupt island integrity.  
     The final adhesive interaction currently characterized entails erythroid intercellular adhesion 
molecule-4 (ICAM-4) binding to macrophage αV integrin. Blocking ICAM-4/αV binding with αV 
synthetic peptides produces a 70% decrease in islands reconstituted in vitro [23]. Moreover, a 
striking decrease in islands reconstituted from marrow of ICAM-4 null mice or formed in vivo in 
these knockout mice is observed [24*]. Collectively, these data provide convincing evidence that 
ICAM-4/αV adhesion participates in island formation. Interestingly, a secreted isoform of mouse 
ICAM-4, ICAM-4S, that is upregulated late in terminal differentiation, has been discovered, 
suggesting a role during this stage of erythropoiesis  [25]. ICAM-4S may compete with 
membrane bound ICAM-4 for integrin counterreceptors, thereby blocking ICAM-4/αV adhesion. 
This potential inhibitory function of ICAM-4S could facilitate detachment of young reticulocytes 
from erythroblastic islands, thereby enabling their movement into the vasculature. 
     Several other macrophage receptors for erythroblasts have been described, however the 
erythroblast counterreceptors have not yet been identified. Macrophages express a membrane 
glycoprotein diffusely localizing to areas of contact with erythroblasts within erythroblastic 
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islands [26]. This macrophage protein, originally called SER (receptor for sheep erythrocytes) 
but now termed sialoadhesion, binds sialylated glycoconjugates [27, 28]. Finally, binding of rat 
erythroblasts  to bone marrow macrophages is inhibited by antibodies to ED2 antigen, a 
macrophage surface component yet to be characterized [29]. 
     Future investigations are likely to uncover additional adhesive interactions between cellular 
components of erythroblastic islands. We can postulate that the various linkages within islands 
are dynamic during erythroid development.  A key unanswered question is what is the role of 
these adhesive molecular attachments?  Given that integrin linkages with the actin cytoskeleton 
regulate intracellular signaling (as reviewed by [30]) certain of these receptor-counterreceptor 
interactions may trigger signaling pathways coordinating adhesion and gene expression.   
REGULATORY FEEDBACK WITHIN ISLANDS           
     It is appealing to speculate that erythropoiesis is driven by both positive and negative 
regulatory feedback mechanisms operating within islands. In support of this thesis, Fas/Fas 
ligand regulation of apoptosis apparently occurs  [31]. Erythroblasts express Fas throughout 
terminal differentiation, however, Fas crosslinking transduces  a death signal in immature but not 
in mature erythroblasts. Hence mature erythroblasts expressing Fas are not susceptible to Fas 
ligand binding. Late in differentiation Fas ligand is induced and orthochromatic erythroblasts 
demonstrate a Fas-based cytotoxicity against Fas expressing immature erythroblasts. 
Importantly, elevated erythropoietin levels, consistent with those present in anemic individuals, 
protect early erythroblasts from Fas-induced cytotoxicity by late erythroblasts. This mechanism 
would upregulate erythropoiesis in response to increased erythropoietin by enabling a greater 
number of immature erythroblasts to complete terminal differentiation. Another feedback 
potentially operating between cellular components of islands involves RCAS1 (receptor binding 
cancer antigen expressed in SiSo cells) and its receptor [32]. Immature erythroblasts express 
RASC1 receptor. Soluble RCAS1, secreted by bone marrow macrophages, activates pro-
apoptotic caspases 8 and 3 in immature erythroblasts. Collectively, these findings delineate 
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possible mechanisms for negative regulatory feedback between mature and immature 
erythroblasts and between macrophages and immature erythroblasts.   
     Erythroblasts differentiating in vivo or in vitro secrete two angiogenic factors, vascular 
endothelial growth factor A (VEGF-A) and placenta growth factor (PIGF) [33]. Media from 
cultured erythroblasts induces migration of monocytes and endothelial cell permeability, both 
inhibited by VEGF-A and PIGF specific antibodies.  Since erythroid progenitors do not express 
receptors for either of these angiogenic factors, the secreted molecules may function as paracrine 
effectors, mediating crosstalk between erythroblasts and receptor-expressing macrophages that 
regulates island structure. Additionally, the angiogenic factors may enable reticulocyte marrow 
egress by affecting endothelial cell junctional integrity.  
     The transcription factor GATA-1 is crucial for erythropoiesis. Absence of GATA-1 
expression results in proerythroblast apoptosis [34, 35, 36, 37] and is embryonic lethal in 
knockout mice [38] whereas overexpression of GATA-1 blocks terminal differentiation [39, 40]. 
Strikingly, the presence of normally expressing cells enables GATA-1 overexpressing cells to 
complete normal terminal differentiation. Using a mouse model in which half of the mouse red 
cells are null for GATA-1 and half overexpress GATA-1 it has been observed that normal late 
stage erythroblasts produce a signal, termed REDS (red cell differentiation signal) that corrects 
the flaw(s) in GATA-1 overexpressing cells [41*]. Mechanistically this appears to involve cell-
cell interaction rather than a soluble factor, underscoring the importance of intercellular 
signaling between erythroblasts in regulating GATA-1 activity and gene expression.  
CENTRAL MACROPHAGE FUNCTION 
     What key functions do central macrophages perform in addition to providing adhesive 
interactions?  It has long been recognized that they phagocytose extruded erythroblast nuclei at 
the conclusion of terminal differentiation [42, 43, 44]. In the fetal liver expelled nuclei rapidly 
expose phosphatidylserine (PS) on their surface after extrusion and are phagocytosed by fetal 
liver macrophages  [45**]. Engulfment of nuclei is blocked by a mutant of milk-fat-globule 
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EGF8 [45**], known to inhibit phagocytosis of apoptotic cells by binding surface PS [46]. 
Extruded nuclei contain markedly decreased ATP and increased Ca2+ [45**]. Together these 
perturbations could inactivate the aminophospholipid translocase and activate the scramblase, 
resulting in movement of PS from the inner to the outer leaflet of the lipid bilayer. Additionally, 
analysis of erythroblast plasma membrane protein partitioning between the reticulocyte and the 
expelled nucleus at the time of enucleation shows that Emp partitions predominantly to the 
plasma membrane surrounding the extruded nucleus [47]. This feature of protein sorting would 
effectively provide extruded nuclei with macrophage binding partners, thereby facilitating 
phagocytosis.  
     Macrophages also secrete cytokines, including burst-promoting activity and insulin-like 
growth factor-1 (IGF-1), that stimulate growth of both burst forming unit-erythroid (BFU-E) and 
colony forming unit –erythroid (CFU-E) [48, 49, 50]. Additionally, erythropoietin mRNA has 
been observed in macrophages [51] although the role that central macrophages play in providing 
erythroblasts either macrophage-synthesized erythropoietin or presenting erythropoietin 
synthesized elsewhere is still under investigation. Another important question yet to be 
conclusively answered is whether central macrophages serve as a source of iron for hemoglobin 
synthesis, as was originally proposed [5]. With the recent exciting advances in our understanding 
of iron transporters and iron metabolism this issue can now be addressed in a meaningful 
manner. 
     Retinoblastoma tumor suppressor (Rb) protein plays a critical role in differentiation of 
macrophages [52**]. This ubiquitously expressed nuclear protein functions in a cell’s choice to 
progress through the cell cycle and divide. The first suggestion that Rb protein might crucially 
affect erythroblastic island function were studies showing that the Rb null phenotype is 
embryonic lethal and that Rb null fetuses are anemic with definitive erythroblasts maturing 
abnormally in fetal liver and failing to enucleate [53, 54, 55]. Rb stimulates macrophage 
differentiation by counteracting the inhibition of Id2 on PU.1, a transcription factor that is a 
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crucial regulator of macrophage differentiation [52**]. Hence, Rb null fetal livers contain far 
fewer mature macrophages and of particular note, Rb deficient fetal liver macrophages do not 
bind Rb null erythroblasts. In contrast, Rb null erythroblasts attached to normal macrophages 
terminally differentiate and enucleate, strongly suggesting that the defect in Rb nulls is extrinsic 
to the erythroblast. Additionally, chimeric mice containing both normal and Rb null cells 
produced normal red cells from Rb null progenitors [56]. Despite these observations, controversy 
exists as to whether the RB null defect is erythroblast intrinsic or extrinsic; indeed, there is some 
evidence that it may be both [17]. Rb null erythroblasts do not differentiate normally in vitro 
[53], and do not undergo cell cycle exit or enucleation normally, thus supporting an additional, 
intrinsic erythroblast defect [57]. Further investigations will be required to clarify these issues.  
LOCALIZATION OF ISLANDS 
     Erythroblastic islands are distributed throughout the marrow, including regions adjacent to 
sinusoids through which reticulocytes enter the circulation. A tantalizing question is whether 
islands are mobile structures and migrate toward sinusoids. Using quantitative light and electron 
microscopy of rat bone marrow, the differentiation stage of erythroblasts in 40 islands adjacent 
to sinusoids and 40 islands nonadjacent has been compared [58]. Islands in all locations contain 
similar numbers of basophilic and polychromatophilic erythroblasts. However, there are 
significantly more proerythroblasts in nonadjacent islands and significantly more acidophilic 
cells in islands neighboring sinusoids, clearly suggesting that erythroblastic islands may migrate 
to sinusoids as the cells within the island become more differentiated. If these observations are 
confirmed one could speculate that crosstalk between developing erythroblasts and the central 
macrophage could stimulate macrophage secretion of proteases that remodel underlying 
extracellular  matrix and enable islands to be released from their original site of matrix 
attachments. 
CONCLUSION 
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     Our understanding of adhesive interactions, cellular cross talk, regulatory feedback pathways 
and intracellular signaling operating within erythroblastic islands is in an early stage. Current 
information opens up many exciting new avenues for exploration and it is hoped that before the 
75th anniversary of the first description of erythroblastic islands we will have a much clearer 
understanding of molecular mechanisms crucial for normal terminal erythroid differentiation 
which occur within these remarkable microenvironmental  niches.      
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